Living legends like Warren Buffett, Rakesh Jhunjhunwala and the other super Gurus have always inspired us to believe that equities are far better than fixed income securities in the long-term. However, an ace fund manager of impeccable credentials has shattered this myth by producing irrefutable data that bonds have actually out-performed equities even over a long period of 21 years
Novice investors like you and me remain in a poverty stricken state throughout our life because of our obsession with the short-term. Motilal Oswal, the founder of MOFSL, has issued the clarion call that we need to think of the long-term if we want to become seriously wealthy
One man’s taboo stock can be another man’s fortune stock. Rakesh Jhunjhunwala, the Badshah of Dalal Street, has given us an unforgettable lesson on how we should learn to apply our own mind and not be fettered by the sayings of other people even if they be investment legends of great stature
The savage crash in stock prices has sent shock waves across the investment community that a 2008-like crises is around the corner. Investors are panic-stricken and are likely to throw in the towel soon. The Gurus have their hands full in trying to soothe the nerves of their followers
Porinju Veliyath’s all-time favourite stock has been battered out of shape and has been abandoned by all savvy investors. However, Warren Buffett’s contrarian call has sparked interest in the sector and the stock
Warren Buffett’s dictates can fox even the savviest of investors. When ace fund manager Samir Arora got perplexed, he sought help and Prof Sanjay Bakshi bailed him out with a clear cut explanation
Though old-school investors of the proven caliber of Rakesh Jhunjhunwala, Prem Watsa, Samir Arora and others offered sensible advice, new-age investors behaved like drunken sailors and poured billions of dollars into dubious e-com ventures run by college dropouts. Now, these ventures are proving to be bottomless pits and the investors are wailing over their losses
After Bill Ackman, Ruane Cunniff, another large shareholder of Valeant Pharma, has rushed to the defense of Valeant Pharma. It complained of experiencing “extraordinary level of pain” at the steep plunge of Valeant’s stock price but gave a clean chit to the beleaguered company and its CEO
Novice investors like you and me have a bad habit of getting carried away with our initial successes in the market. We begin to believe that we are brilliant and destined for great riches. We get carried away and take bigger risks. Then, we land in trouble and feel sorry for ourselves. Durgesh Shah’s timely advice can save us from ourselves
Warren Buffett’s Berkshire Hathaway & Parag Parikh’s PPFAS MF have pumped in large sums of money into a blue chip tech behemoth which appears to be sinking under its own weight. Are these stalwarts in a state of denial or do they know something that other investors do not?
Recent Comments